Characterization of patients diagnosed with vulvar lichen sclerosus
Keywords:
VULVAR LICHEN SCLEROSUS, VULVAR PRURITUS, VULVAR NEOPLASMS.Abstract
Introduction: Vulvar lichen sclerosus is a chronic and progressive inflammatory dermatosis, underdiagnosed and undertreated, with a tendency to malignancy. Timely diagnosis and early treatment are essential.
Objective: To characterize patients with a diagnosis of vulvar lichen sclerosus attended in the health areas of Chambas municipality, Ciego de Avila.
Methods: An observational, descriptive, cross-sectional, case series study was conducted. The sample coincides with the universe so the sampling was intentional non-probabilistic. Women with vulvar lichen sclerosus, treated in Chambas municipality from January 2015 to September 2022, were included, patients with incomplete medical histories were excluded. Absolute and relative frequencies (percentage) were used as a summary measure.
Results: There was a predominance of the age group 60-69 years (66,7 %) and white skin color (71,4 %). 52,4 % belonged to the white group. The 52,4 % belonged to the Julio Castillo area. The mean age was 64,8±6,217 years. Vulvar pruritus and hypopigmentation were present in 100 % of the patients. Differentiated vulvar intraepithelial neoplasia developed in 61,9 % of the women. In 48,2 % of the cases the time of evolution was longer than three years. They received surgical treatment 71,4 %.
Conclusions: The disease predominated in the elderly; Hypopigmentation and vulvar pruritus were a constant in the patients studied, most developed a differentiated vulvar intraepithelial neoplasia with more than three years of evolution of the lesions and surgical treatment was the most applied behavior.
Downloads
References
1. Torres M, Dubeibe P, Pareja M. UVA-1 phototherapy for the treatment of genital lichen sclerosus. Dermatol Rev Mex [Internet]. 2021 [citado 12/04/2022]; 65(2): 159-165. Disponible en: https://dermatologiarevistamexicana.org.mx/article/fototerapia-uva-1-en-el-tratamiento-del-liquen-escleroso-y-atrofico-vulvar/
2. Gómez Chaves G, Sequeira Araya A, Rodríguez Vega MF. Actualización en liquen escleroso vulvar en población adulta. Rev.Méd.Sinerg [Internet]. 2022 [citado 12/04/2022]; 7(8): e853. Disponible en: https://revistamedicasinergia.com/index.php/rms/article/view/853
3. Macías Yanes JC, Trujillo Betancourt M, Galván Sánchez L, Leonard Díaz D, Estrada Sánchez T, Leyva Almeida H. Liquen escleroso atrófico con vitiligo en pediatría. Rev. Finlay [Internet]. 2021 [citado 12/09/22]; 11(1): 59-65. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S2221-24342021000100059
4. Rucci-Bentancor N. Monografía: Manejo terapéutico del Liquen Escleroso vulvar [Internet]. Uruguay. Facultad de Medicina de la República Oriental del Uruguay; 2018 [citado 26/03/2021]. Disponible en: https://www.ginecotocologicab.hc.edu.uy/images/Monograf%C3%ADa_Liquen.pdf
5. Arias Florez F, Sehtman A, Navajas D, Allevato M. Liquen Escleroso. Dermatol Argent [Internet]. 2016 [citado: 26/03/2021]; 22(1): 05-12. Disponible en: https://www.dermatlolarg.org.ar/index.php/dermatolarg/article/view/1466
6. Caussade A. Liquen escleroso: actualización. Archivos de Ginecología y Obstetricia [Internet]. 2019 [citado 26/03/2021]; 57(1): 31–54. Disponible en: https://ago.uy/publicación/1/numeros/6/article/liquen-escleroso-actualización-lichen-sclerosus-an-update
7. Cararach M, Castro M, García A, Juliá M, Mascaró JM, Quílez JC, et al. AEPCC-Guía: Dermatosis inflamatoria de la vulva (liquen escleroso, liquen plano y liquen simple crónico) [Internet]. Publicaciones AEPCC; 2016 [citado 26/03/2021]. p.1-52. Disponible en: https://www.aepcc.org/wp-content/uploads/2016/12/AEPCC_revista06-DermatosisInfVulv.pdf
8. Asociación Médica Mundial. Declaración de Helsinki de la AMM. Principios éticos para las investigaciones médicas en seres humanos. Ratificada en la 64ª Asamblea General, Fortaleza, Brasil, octubre 2013 [Internet]. Helsinki: 18ª Asamblea Mundial; 1964 [citado: 26/02/2022]. Disponible en: https://www.wma.net/es/policies-post/declaracion-de-helsinki-de-la-amm-principios-eticos-para-las-investigaciones-medicas-en-seres-humanos/
9. Singh N, Ghatage P. Etiología, características clínicas y diagnóstico del liquen escleroso vulvar: una revisión de alcance. Obstet Gynecol Int [Internet]. 2020 [citado 26/02/2022]; 2020(7480754). Disponible en: https://www.hindawi.com/journals/ogi/2020/7480754/
10. Castro do Rêgo Barros C. Aspectos clínicos e epidemiológicos de mulheres com líquen escleroso atendidas no Hospital das Clínicas [Internet]. Brasil: Universidade Federal de Pernambuco. Recife; 2019 [citado: 26/02/2022]. Disponible en: https://repositorio.ufpe.br/bitstream/123456789/35344/1/DISSERTA%c3%87%c3%83O%20Cl%c3%a1udia%20Renata%20Castro%20do%20R%c3%aago%20Barros%20Albuquerque.pdf
11. Cabrera-Acea G, Hernández-Mompié J, Gómez-Cabrera C. Liquen escleroso y atrófico genital o craurosis de la vulva. Presentación de un caso. Medisur [Internet]. 2016 [citado 26/03/2021]; 14(6): 796-800. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1727-897X2016000600018
12. Barchino Ortiz L. Liquen escleroso vulvar: estudio descriptivo epidemiológico, clínico e histológico de las pacientes de una consulta monográfica de dermatología ginecológica. [Tesis Doctoral]. Madrid: Universidad Complutense de Madrid. Facultad de Medicina; 2021 [citado 26/02/2022]. Disponible en: https://eprints.ucm.es/id/eprint/67462/1/T42812.pdf
13. Cortés Ros O, Matos Figueredo F, Gahona Kross T, Villacrés Medina L. Liquen escleroso atrófico genital y extragenital diseminado. Presentación de un caso. Medisur [Internet]. 2013 [citado: 26/03/2021]; 11(6): 685-689. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1727-897X2013000600010&lng=es
14. Hinojal Toscano I, Zamorano Alanís B, Martínez Maestre M. Revisión del tratamiento actual del liquen escleroso vulvar. Arch Inv Mat Inf [Internet]. 2020 [citado: 26/03/2021]; 11(2): 82-90. Disponible en: https://www.medigraphic.com/cgi-bin/new/resumen.cgi?IDARTICULO=101555
15. Manzo-Carrillo L, Ramírez-Fuentes K, Cabrera-Rivero KE. Liquen escleroso y atrófico asociado a cáncer vulvar (Carcinoma epidermoide moderadamente diferenciado, ulcerado e invasor de clítoris). Congreso Mexicano de Obstetricia y Ginecolóógía, Guadalajara; 2022 [citado: 26/02/2022]. Disponible en: https://femecog.org.mx/categoria5/CC-88.pdf
16. Gutiérrez-Pascual M, Vicente-Martín FJ, López-Estebaranz JL. Liquen escleroso y carcinoma escamoso. Actas Dermo-Sifiliográficas [Internet]. 2012 [citado: 26/03/2021]; 103(1): 21-28. Disponible en: https://www.actasdermo.org/es-liquen-escleroso-carcinoma-escamoso-articulo-S0001731011002857
17. Falcón MF, Paradeda ME, García KF, Maldonado V, Díaz L, Cardinal L. Inmunohistoquímica de p16 y p53 en cáncer de vulva. Medicina (B. Aires) [Internet]. 2020 [citado 26/03/2021]; 80(2): 127-133. Disponible en: http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0025-76802020000300005&lng=es.
18. Reolid PA, Muñoz AE, Rodríguez JP, Llamas MM, Gordillo C, Daudén E. Asociación del virus del papiloma humano tipo 6 con liquen escleroso hipertrófico. Med Cut Ibero-Latino-Am [Internet]. 2018 [citado 27/04/2021]; 46(1): 56-58. Disponible en: https://www.medigraphic.com/pdfs/cutanea/mc-2018/mc181k.pdf
19. Vieira-Baptista P, Pérez-López FR, López-Baena MT, Stockdale CK, Preti M, Bornstein J. Riesgo de desarrollo de cáncer de vulva en mujeres con liquen escleroso o liquen plano: una revisión sistemática. J Enfermedad del tracto genital inferior [Internet]. 2022 [citado 27/04/2021]; 26(3): 250-257. Disponible en: http://journals.lww.com/jlgtd/fulltext/2022/07000/risk_of_development_of_vulvar_cancer_in_woman_with.9.aspx
20. Álvarez Gil C, Sanz Baro R, Blanco Herraez I, Ferreira Borrego IM, Pineda Domínguez L, Redondo Guisasola C. Neoplasia intraepitelial vulvar: Cribado en población de riesgo. Clínica e Investigación en Ginecología y Obstetricia [Internet]. 2021 [citado 27/04/2021]; 48(2): 117-121. Disponible en: https://www.sciencedirect.com/science/article/abs/pii/S0210573X20301088
Downloads
Published
How to Cite
Issue
Section
License
Authors who have publications with this journal agree to the following terms: Authors will retain their copyrights and grant the journal the right of first publication of their work, which will be publication of their work, which will be simultaneously subject to the Creative Commons Attribution License (CC-BY-NC 4.0) that allows third parties to share the work as long as its author and first publication in this journal are indicated.
Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g.: deposit it in an institutional telematic archive or publish it in a volume). Likewise, and according to the recommendations of the Medical Sciences Editorial (ECIMED), authors must declare in each article their contribution according to the CRediT taxonomy (contributor roles). This taxonomy includes 14 roles, which can be used to represent the tasks typically performed by contributors in scientific academic production. It should be consulted in monograph) whenever initial publication in this journal is indicated. Authors are allowed and encouraged to disseminate their work through the Internet (e.g., in institutional telematic archives or on their web page) before and during the submission process, which may produce interesting exchanges and increase citations of the published work. (See The effect of open access). https://casrai.org/credit/
